首页 > 最新文献

Primary care diabetes最新文献

英文 中文
Prevalence of painful and painless diabetic peripheral neuropathy in the Northern Danish Region: A population-based study. 丹麦北部地区疼痛性和无痛性糖尿病周围神经病变的发病率:一项基于人口的研究。
Pub Date : 2024-08-30 DOI: 10.1016/j.pcd.2024.08.006
Johan Røikjer, Anne-Marie Wegeberg, Amar Nikontovic, Christina Brock, Peter Vestergaard

Background: Diabetic peripheral neuropathy (DPN) is a common complication of diabetes, yet varying estimates of its prevalence exist. The present study aimed to estimate a questionnaire-centered prevalence of painful and painless DPN in the Northern Danish Region, examine its geographical distribution within the region, and investigate associations between DPN and potential risk factors.

Methods: A questionnaire-based survey was sent to all persons living with diabetes in the Northern Danish Region using electronic mail. Persons with diabetes were identified using The National Health Insurance Service Registry. The survey included information on demographics, socioeconomics, municipality, diabetes type, duration, and treatment, as well as the validated questionnaires Michigan Neuropathy Screening Instrument-questionnaire (MNSIq) and the Douleur Neuropathique en 4 Questions (DN4)-interview. Possible DPN was defined as an MNSIq-score ≥ 4, while possible painful DPN was defined as pain in both feet and a DN4-interview score ≥ 3.

Results: A total of 23,206 eligible people were identified as having diabetes and approximately 33 % answered all questionnaires. The prevalence of possible DPN was 23.3 % (95 % CI: 22.4-24.3 %), while the prevalence of possible painful DPN was 18.0 % (17.1-18.8 %). The prevalence of possible DPN ranged from 22.1 % to 35.0 % between municipalities, while the prevalence of possible painful DPN ranged from 15.6 % to 20.0 %. High body-mass index, long diabetes duration, insulin use, glucagon-like-peptide-1-analogue use, and low income were associated with increased risk of DPN.

Conclusion: The high prevalence of possible painless and painful DPN emphasizes the need for better prevention and careful screening even in high-income countries.

背景:糖尿病周围神经病变(DPN)是糖尿病的一种常见并发症,但对其患病率的估计却不尽相同。本研究旨在以问卷为中心估算丹麦北部地区疼痛型和无痛型 DPN 的患病率,研究其在该地区的地理分布,并调查 DPN 与潜在风险因素之间的关联:通过电子邮件向丹麦北部地区的所有糖尿病患者发送了问卷调查。糖尿病患者的身份是通过国家医疗保险服务登记处确定的。调查内容包括人口统计学、社会经济学、城市、糖尿病类型、病程和治疗等方面的信息,以及经过验证的密歇根神经病变筛查工具问卷(MNSIq)和Douleur Neuropathique en 4 Questions(DN4)访谈问卷。MNSIq得分≥4分为可能的DPN,双脚疼痛且DN4-访谈得分≥3分为可能的疼痛性DPN:共有 23 206 名符合条件的糖尿病患者被确定为糖尿病患者,其中约 33% 回答了所有问卷。可能的 DPN 患病率为 23.3%(95% CI:22.4-24.3%),可能的 DPN 疼痛患病率为 18.0%(17.1-18.8%)。各城市之间可能发生 DPN 的比例从 22.1 % 到 35.0 % 不等,而可能发生疼痛性 DPN 的比例从 15.6 % 到 20.0 % 不等。高体重指数、糖尿病病程长、使用胰岛素、使用胰高血糖素样肽-1-类似物和低收入与 DPN 风险增加有关:结论:即使在高收入国家,无痛和有痛 DPN 的高发病率也强调了加强预防和仔细筛查的必要性。
{"title":"Prevalence of painful and painless diabetic peripheral neuropathy in the Northern Danish Region: A population-based study.","authors":"Johan Røikjer, Anne-Marie Wegeberg, Amar Nikontovic, Christina Brock, Peter Vestergaard","doi":"10.1016/j.pcd.2024.08.006","DOIUrl":"https://doi.org/10.1016/j.pcd.2024.08.006","url":null,"abstract":"<p><strong>Background: </strong>Diabetic peripheral neuropathy (DPN) is a common complication of diabetes, yet varying estimates of its prevalence exist. The present study aimed to estimate a questionnaire-centered prevalence of painful and painless DPN in the Northern Danish Region, examine its geographical distribution within the region, and investigate associations between DPN and potential risk factors.</p><p><strong>Methods: </strong>A questionnaire-based survey was sent to all persons living with diabetes in the Northern Danish Region using electronic mail. Persons with diabetes were identified using The National Health Insurance Service Registry. The survey included information on demographics, socioeconomics, municipality, diabetes type, duration, and treatment, as well as the validated questionnaires Michigan Neuropathy Screening Instrument-questionnaire (MNSIq) and the Douleur Neuropathique en 4 Questions (DN4)-interview. Possible DPN was defined as an MNSIq-score ≥ 4, while possible painful DPN was defined as pain in both feet and a DN4-interview score ≥ 3.</p><p><strong>Results: </strong>A total of 23,206 eligible people were identified as having diabetes and approximately 33 % answered all questionnaires. The prevalence of possible DPN was 23.3 % (95 % CI: 22.4-24.3 %), while the prevalence of possible painful DPN was 18.0 % (17.1-18.8 %). The prevalence of possible DPN ranged from 22.1 % to 35.0 % between municipalities, while the prevalence of possible painful DPN ranged from 15.6 % to 20.0 %. High body-mass index, long diabetes duration, insulin use, glucagon-like-peptide-1-analogue use, and low income were associated with increased risk of DPN.</p><p><strong>Conclusion: </strong>The high prevalence of possible painless and painful DPN emphasizes the need for better prevention and careful screening even in high-income countries.</p>","PeriodicalId":94177,"journal":{"name":"Primary care diabetes","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142116644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sleep well, but be active. Effect of sleep and sedentariness on incidence of diabetes. 睡得好,但要活跃。睡眠和久坐对糖尿病发病率的影响。
Pub Date : 2023-05-24 DOI: 10.1093/eurjpc/zwad125.106
Keyuan Liu, P. Marques-Vidal
AIMSWe aimed to determine the individual effect of long/short sleep and of inactivity on diabetes risk using data from a population-based prospective study in Switzerland.METHODSProspective study with a median (min-max) follow-up of 9 (2.4-11.5) years. Incident diabetes was defined based on 1) fasting plasma glucose (FPG), 2) glycated hemoglobin (HbA1c), or 3) any diagnostic criterion (FPG, HbA1c or medical diagnosis). Sleep and sedentary levels were assessed by questionnaire. Sleep was categorized into short (<7 h/day), adequate (7-9 h/day) and long (>9 h/day).RESULTSData from 3355 participants (57.6% women, mean age years 56.6 ± 10.3) was analyzed. There were 136, 110 and 142 incident cases of diabetes defined by FPG, HbA1c or any criterion, respectively. Participants who developed diabetes had a higher sedentariness but no differences were found regarding sleep duration. Similar results were obtained after adjusting for age, gender, education, smoking and body mass index: hazard ratio (95% confidence interval) for sedentariness 1.61 (1.11-2.35), 1.40 (0.93-2.12) and 1.39 (1.04-1.87) for diabetes defined by FPG, HbA1c or any diagnostic criterion, respectively.CONCLUSIONBeing sedentary, but not being a long or a short sleeper, increases the risk of developing diabetes.
目的:我们旨在利用瑞士一项基于人群的前瞻性研究的数据,确定长/短睡眠和不活动对糖尿病风险的个体影响。方法前瞻性研究,中位(最小-最大)随访时间为9年(2.4-11.5)年。偶发性糖尿病的定义基于1)空腹血糖(FPG), 2)糖化血红蛋白(HbA1c),或3)任何诊断标准(FPG, HbA1c或医学诊断)。通过问卷调查评估睡眠和久坐时间。睡眠分为短睡眠(9小时/天)。结果共纳入3355名参与者(女性57.6%,平均年龄56.6±10.3岁)。FPG、HbA1c或其他标准定义的糖尿病发生率分别为136、110和142例。患有糖尿病的参与者久坐时间更长,但睡眠时间没有发现差异。在调整了年龄、性别、教育程度、吸烟和体重指数后,得到了类似的结果:对于FPG、HbA1c或任何诊断标准定义的糖尿病,久坐的风险比(95%置信区间)分别为1.61(1.11-2.35)、1.40(0.93-2.12)和1.39(1.04-1.87)。结论久坐不动,但不是长睡眠或短睡眠,会增加患糖尿病的风险。
{"title":"Sleep well, but be active. Effect of sleep and sedentariness on incidence of diabetes.","authors":"Keyuan Liu, P. Marques-Vidal","doi":"10.1093/eurjpc/zwad125.106","DOIUrl":"https://doi.org/10.1093/eurjpc/zwad125.106","url":null,"abstract":"AIMS\u0000We aimed to determine the individual effect of long/short sleep and of inactivity on diabetes risk using data from a population-based prospective study in Switzerland.\u0000\u0000\u0000METHODS\u0000Prospective study with a median (min-max) follow-up of 9 (2.4-11.5) years. Incident diabetes was defined based on 1) fasting plasma glucose (FPG), 2) glycated hemoglobin (HbA1c), or 3) any diagnostic criterion (FPG, HbA1c or medical diagnosis). Sleep and sedentary levels were assessed by questionnaire. Sleep was categorized into short (<7 h/day), adequate (7-9 h/day) and long (>9 h/day).\u0000\u0000\u0000RESULTS\u0000Data from 3355 participants (57.6% women, mean age years 56.6 ± 10.3) was analyzed. There were 136, 110 and 142 incident cases of diabetes defined by FPG, HbA1c or any criterion, respectively. Participants who developed diabetes had a higher sedentariness but no differences were found regarding sleep duration. Similar results were obtained after adjusting for age, gender, education, smoking and body mass index: hazard ratio (95% confidence interval) for sedentariness 1.61 (1.11-2.35), 1.40 (0.93-2.12) and 1.39 (1.04-1.87) for diabetes defined by FPG, HbA1c or any diagnostic criterion, respectively.\u0000\u0000\u0000CONCLUSION\u0000Being sedentary, but not being a long or a short sleeper, increases the risk of developing diabetes.","PeriodicalId":94177,"journal":{"name":"Primary care diabetes","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42061845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effectiveness of Enhanced Primary Healthcare (EnPHC) interventions on Type 2 diabetes management in Malaysia: Difference-in-differences (DID) analysis. 马来西亚加强初级保健(EnPHC)干预对2型糖尿病管理的有效性:差异中的差异(DID)分析。
Pub Date : 2021-01-28 DOI: 10.21203/RS.3.RS-154502/V1
M. Husin, X. Teh, S. M. Ong, Y. Lim, Swee Hung Ang, C. Chan, M. Lim, S. Shanmugam, Noraziani Khamis, Faeiz Syezri Adzmin Jaafar, Norliza Ibrahim, N. Nasir, D. Kusuma, A. Wagner, D. Ross-Degnan, R. Atun, S. Sivasampu
AIMSTo evaluate the effectiveness of the Enhanced Primary Healthcare (EnPHC) interventions on process of care and intermediate clinical outcomes among type 2 diabetes patients.METHODSThis was a quasi-experimental controlled study conducted in 20 intervention and 20 control public primary care clinics in Malaysia from November 2016 to June 2019. Type 2 diabetes patients aged 30 years and above were selected via systematic random sampling. Outcomes include process of care and intermediate clinical outcomes. Difference-in-differences analyses was conducted.RESULTSWe reviewed 12,017 medical records of patients with type 2 diabetes. Seven process of care measures improved: HbA1c tests (odds ratio (OR) 3.31, 95% CI 2.13, 5.13); lipid test (OR 4.59, 95% CI 2.64, 7.97), LDL (OR 4.33, 95% CI 2.16, 8.70), and urine albumin (OR 1.99, 95% CI 1.12, 3.55) tests; BMI measured (OR 15.80, 95% CI 4.78, 52.24); cardiovascular risk assessment (OR 174.65, 95% CI 16.84, 1810.80); and exercise counselling (OR 1.18, 95% CI 1.04, 1.33). We found no statistically significant changes in intermediate clinical outcomes (i.e. HbA1c, LDL, HDL and BP control).CONCLUSIONSEnPHC interventions was successful in enhancing the quality of care, in terms of process of care, by changing healthcare providers behaviour.
目的评估强化初级保健(EnPHC)干预措施对2型糖尿病患者护理过程和中期临床结果的有效性。方法这是一项准实验对照研究,于2016年11月至2019年6月在马来西亚的20家干预和20家对照公立初级保健诊所进行。通过系统随机抽样选择年龄在30岁及以上的2型糖尿病患者。结果包括护理过程和中期临床结果。进行了差异中的差异分析。结果我们查阅了12017份2型糖尿病患者的病历。改善了七项护理过程测量:HbA1c测试(比值比(OR)3.31,95%CI 2.13,5.13);脂质测试(OR 4.59,95%CI 2.64,7.97)、低密度脂蛋白(OR 4.33,95%CI 2.16,8.70)和尿白蛋白(OR 1.99,95%CI 1.12,3.55)测试;测量的BMI(OR 15.80,95%CI 4.78,52.24);心血管风险评估(OR 174.65,95%CI 16.84810.80);和运动咨询(OR 1.18,95%CI 1.04,1.33)。我们发现中间临床结果(即HbA1c、LDL、HDL和BP对照)没有统计学上的显著变化。结论nPHC干预措施通过改变医疗保健提供者的行为,在护理过程方面成功地提高了护理质量。
{"title":"The Effectiveness of Enhanced Primary Healthcare (EnPHC) interventions on Type 2 diabetes management in Malaysia: Difference-in-differences (DID) analysis.","authors":"M. Husin, X. Teh, S. M. Ong, Y. Lim, Swee Hung Ang, C. Chan, M. Lim, S. Shanmugam, Noraziani Khamis, Faeiz Syezri Adzmin Jaafar, Norliza Ibrahim, N. Nasir, D. Kusuma, A. Wagner, D. Ross-Degnan, R. Atun, S. Sivasampu","doi":"10.21203/RS.3.RS-154502/V1","DOIUrl":"https://doi.org/10.21203/RS.3.RS-154502/V1","url":null,"abstract":"AIMS\u0000To evaluate the effectiveness of the Enhanced Primary Healthcare (EnPHC) interventions on process of care and intermediate clinical outcomes among type 2 diabetes patients.\u0000\u0000\u0000METHODS\u0000This was a quasi-experimental controlled study conducted in 20 intervention and 20 control public primary care clinics in Malaysia from November 2016 to June 2019. Type 2 diabetes patients aged 30 years and above were selected via systematic random sampling. Outcomes include process of care and intermediate clinical outcomes. Difference-in-differences analyses was conducted.\u0000\u0000\u0000RESULTS\u0000We reviewed 12,017 medical records of patients with type 2 diabetes. Seven process of care measures improved: HbA1c tests (odds ratio (OR) 3.31, 95% CI 2.13, 5.13); lipid test (OR 4.59, 95% CI 2.64, 7.97), LDL (OR 4.33, 95% CI 2.16, 8.70), and urine albumin (OR 1.99, 95% CI 1.12, 3.55) tests; BMI measured (OR 15.80, 95% CI 4.78, 52.24); cardiovascular risk assessment (OR 174.65, 95% CI 16.84, 1810.80); and exercise counselling (OR 1.18, 95% CI 1.04, 1.33). We found no statistically significant changes in intermediate clinical outcomes (i.e. HbA1c, LDL, HDL and BP control).\u0000\u0000\u0000CONCLUSIONS\u0000EnPHC interventions was successful in enhancing the quality of care, in terms of process of care, by changing healthcare providers behaviour.","PeriodicalId":94177,"journal":{"name":"Primary care diabetes","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45092402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of restricted diet with a plate in patients with type 2 diabetes: A randomized controlled trial. 餐盘限制饮食对2型糖尿病患者的有效性:一项随机对照试验。
Pub Date : 2020-11-16 DOI: 10.22541/au.160552637.79851951/v1
Yongwen Zhang, Huanhuan Han, Lanfang Lanfang
BACKGROUNDIn view of the complexity of dietary and nutritional education for most patients with type 2 diabetes mellitus (T2DM), a simplified approach called the "restricted diet with a plate" or "plate model" is recommended.PURPOSETo evaluate whether the plate model can effectively improve glycemic control and cardiovascular risk markers in type 2 diabetes mellitus (T2DM), while reducing the time devoted to education and avoiding weight gain.METHODSThe study was a randomized, multicenter, controlled study, conducted between October 2018 and October 2019, among patients with T2DM living in Nanjing. The study included 419 participants who were randomly divided into a plate group and a counting group. The plate model included three components: a low-literacy, color leaflet containing the explanation and composition of the plate model, health education, and medical visits. Patients in the counting group received health education, group medical visits, and a paper booklet containing traditional carbohydrate counting education. Primary outcomes were glycemic control and weight.RESULTSParticipants in the plate model reduced HbA1c by 0.7% in the first three months, and reduced to a greater extent at six months (1.44%), but this was not sustained, and HbA1c increased slightly over the following six months. Fasting plasma glucose (FPG) and 2-h postprandial glucose (2hPG) values were significantly reduced at the endpoint in the plate model (9.25 ± 1.72% vs. 7.44 ± 0.88%, P = 0.008; 12.07 ± 2.94 vs. 8.35 ± 1.99%; P = 0.004); however, the 2hPG values decreased most significantly. Total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) levels decreased significantly in the plate group, which occurred at six months and lasted for 12 months. In the first three months, the average weight loss in the plate group was 1.2 kg/month (95% CI 0.92-1.48), and in the fourth to twelfth months, the average weight gain was 0.21 kg/month (95% CI 0.08-0.34). There was significant difference in education time between the groups (17.3 ± 4.42 vs. 38.6 ± 12.63; P < 0.001).CONCLUSIONSThe plate model is at least as effective as the counting model over the short term for glycemic control and perhaps even better for weight and lipid control. Plate model has the potential to improve education of those with low health literacy by reducing reading demands.
背景鉴于大多数2型糖尿病(T2DM)患者的饮食和营养教育的复杂性,建议采用一种简化的方法,称为“限制性平板饮食”或“平板模式”。目的评估平板模型是否能有效改善2型糖尿病(T2DM)的血糖控制和心血管风险标志物,同时减少教育时间并避免体重增加。方法本研究是一项随机、多中心、对照研究,于2018年10月至2019年10月在南京生活的T2DM患者中进行。这项研究包括419名参与者,他们被随机分为平板组和计数组。平板模型包括三个组成部分:一份低识字率的彩色传单,其中包含平板模型的解释和组成、健康教育和医疗访问。计数组的患者接受了健康教育、集体医疗访问和一本包含传统碳水化合物计数教育的纸质小册子。主要结果是血糖控制和体重。结果平板模型的参与者在前三个月内HbA1c降低了0.7%,在六个月时降低了更大程度(1.44%),但这并没有持续下去,在接下来的六个月里HbA1c略有增加。在平板模型的终点,空腹血糖(FPG)和餐后2小时血糖(2hPG)值显著降低(9.25±1.72%对7.44±0.88%,P=0.008;12.07±2.94对8.35±1.99%;P=0.004);2hPG值下降最为显著。平板组总胆固醇(TC)和低密度脂蛋白胆固醇(LDL-C)水平显著下降,出现在6个月,持续12个月。在前三个月,平板组的平均体重减轻了1.2公斤/月(95%CI 0.92-1.48),在第四到第十二个月,平均体重增加0.21kg/月(95%CI 0.08-0.34)。两组之间的受教育时间有显著差异(17.3±4.42 vs.38.6±12.63;P<0.001)。结论平板模型在血糖控制方面至少与计数模型一样有效,在体重和脂质控制方面可能更好。平板模式有可能通过减少阅读需求来改善低健康素养人群的教育。
{"title":"Effectiveness of restricted diet with a plate in patients with type 2 diabetes: A randomized controlled trial.","authors":"Yongwen Zhang, Huanhuan Han, Lanfang Lanfang","doi":"10.22541/au.160552637.79851951/v1","DOIUrl":"https://doi.org/10.22541/au.160552637.79851951/v1","url":null,"abstract":"BACKGROUND\u0000In view of the complexity of dietary and nutritional education for most patients with type 2 diabetes mellitus (T2DM), a simplified approach called the \"restricted diet with a plate\" or \"plate model\" is recommended.\u0000\u0000\u0000PURPOSE\u0000To evaluate whether the plate model can effectively improve glycemic control and cardiovascular risk markers in type 2 diabetes mellitus (T2DM), while reducing the time devoted to education and avoiding weight gain.\u0000\u0000\u0000METHODS\u0000The study was a randomized, multicenter, controlled study, conducted between October 2018 and October 2019, among patients with T2DM living in Nanjing. The study included 419 participants who were randomly divided into a plate group and a counting group. The plate model included three components: a low-literacy, color leaflet containing the explanation and composition of the plate model, health education, and medical visits. Patients in the counting group received health education, group medical visits, and a paper booklet containing traditional carbohydrate counting education. Primary outcomes were glycemic control and weight.\u0000\u0000\u0000RESULTS\u0000Participants in the plate model reduced HbA1c by 0.7% in the first three months, and reduced to a greater extent at six months (1.44%), but this was not sustained, and HbA1c increased slightly over the following six months. Fasting plasma glucose (FPG) and 2-h postprandial glucose (2hPG) values were significantly reduced at the endpoint in the plate model (9.25 ± 1.72% vs. 7.44 ± 0.88%, P = 0.008; 12.07 ± 2.94 vs. 8.35 ± 1.99%; P = 0.004); however, the 2hPG values decreased most significantly. Total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) levels decreased significantly in the plate group, which occurred at six months and lasted for 12 months. In the first three months, the average weight loss in the plate group was 1.2 kg/month (95% CI 0.92-1.48), and in the fourth to twelfth months, the average weight gain was 0.21 kg/month (95% CI 0.08-0.34). There was significant difference in education time between the groups (17.3 ± 4.42 vs. 38.6 ± 12.63; P < 0.001).\u0000\u0000\u0000CONCLUSIONS\u0000The plate model is at least as effective as the counting model over the short term for glycemic control and perhaps even better for weight and lipid control. Plate model has the potential to improve education of those with low health literacy by reducing reading demands.","PeriodicalId":94177,"journal":{"name":"Primary care diabetes","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42015834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Progression of pregnancy induced diabetes mellitus to type two diabetes mellitus, an ambidirectional cohort study. 妊娠期糖尿病向2型糖尿病的进展,一项双向队列研究。
Pub Date : 2020-06-08 DOI: 10.21203/rs.3.rs-30572/v1
B. Feleke, Teferi Elfu Feleke, M. Kassahun, Wondemu Gebrekirose Adane, Desalegn Achenefe, Abere Genetu, Azezu Asres Nigussie, Hailemariam Awoke Engedaw
INTRODUCTIONDiabetes mellitus (DM) is a metabolic disorder characterized by elevated level of blood glucose. It affects more than 422 million people globally. In resource limited settings, the progression of gestational diabetes (GDM) to DM was not well investigated and this research work was conducted to estimate the incidence of DM after GDM and their predictors in resource limited settings.METHODSA retrospective and prospective cohort studies were used from January 2010 until December 2019. The data were collected using patients chart review, interview and collecting blood sample. Initially, baseline data were collected from GDM and GDM free women and update data were collected every 3 month. Clinical nurses were used to extract the necessary data from medical charts and to collect the data using patient interview. Laboratory technologists were used to measure the blood glucose level of the study participants. The study was conducted in pregnant women presenting themselves in the referral hospitals of Amhara regional state. The sample size was calculated using Epi-info software. Descriptive statistics were used to describe the profile of study participants. Kaplan Meier survival curve and life-table were used to estimate the survivals of study participants. Incidence density was used to estimate the incidence of DM. Cox regression was used to identify the predictors DM.RESULTSA total of 4892 women were followed giving for the response rate of 88.62%. The mean age of study participants at the start of the study was 28.34 years with standard deviation [SD] ±7.48 years. DM was associated with gestational diabetes mellitus [AHR (adjusted hazard ratio); 2.53, 95% CI: 2.14-2.99], frequency of breastfeeding [AHR; 0.72, 95% CI: 0.69-0.74], age [AHR; 1.04, 95% CI: 1.03-1.05], parity [AHR; 1.14, 95% CI: 1.07-1.21], regular physical exercise [AHR; 0.45, 95% CI: 0.37-0.55], family history of DM [AHR; 2.04, 95% CI: 1.76-2.37], stillbirth [AHR; 1.67: 95% CI: 1.34-2.07], abortion [AHR; 2.64, 95% CI: 2.25-3.09].CONCLUSIONThe progression of GDM to DM was very high and special follow up should be implemented for women with a history of abortion, stillbirth, and family history of DM.
引言糖尿病是一种以血糖升高为特征的代谢紊乱。它影响着全球超过4.22亿人。在资源有限的环境中,妊娠期糖尿病(GDM)发展为糖尿病的情况没有得到很好的调查,本研究工作旨在评估GDM后糖尿病的发病率及其在资源有限环境中的预测因素。方法从2010年1月至2019年12月进行回顾性和前瞻性队列研究。数据是通过患者病历回顾、访谈和采集血样收集的。最初,从GDM和无GDM的女性中收集基线数据,每3个月收集一次更新数据。临床护士被用来从病历中提取必要的数据,并通过患者访谈收集数据。实验室技术人员被用来测量研究参与者的血糖水平。这项研究是在阿姆哈拉州转诊医院的孕妇中进行的。使用Epi-info软件计算样本量。描述性统计用于描述研究参与者的概况。Kaplan-Meier生存曲线和生命表用于估计研究参与者的生存率。发病率密度用于估计糖尿病的发病率。Cox回归用于确定糖尿病的预测因素。对4892名女性进行了随访,有效率为88.62%。研究开始时,研究参与者的平均年龄为28.34岁,标准差[SD]±7.48岁。糖尿病与妊娠期糖尿病相关[AHR(调整后的危险比);2.53,95%CI:2.14-2.99],母乳喂养频率[AHR;0.72,95%CI:0.69-0.74],年龄[AHR;1.04,95%CI:1.03-1.05],产次[AHR;1.14,95%CI:1.07-1.21],定期体育锻炼[AHR;0.45,95%CI:0.37-0.55],糖尿病家族史[AHR;2.04,95%CI+1.76-2.37],死产[AHR;1.67:95%CI:1.34-2.07],流产[AHR;2.64,95%CI:2.25-3.09]。结论GDM向DM的进展非常高,对有流产史、死产史和DM家族史的妇女应进行特殊随访。
{"title":"Progression of pregnancy induced diabetes mellitus to type two diabetes mellitus, an ambidirectional cohort study.","authors":"B. Feleke, Teferi Elfu Feleke, M. Kassahun, Wondemu Gebrekirose Adane, Desalegn Achenefe, Abere Genetu, Azezu Asres Nigussie, Hailemariam Awoke Engedaw","doi":"10.21203/rs.3.rs-30572/v1","DOIUrl":"https://doi.org/10.21203/rs.3.rs-30572/v1","url":null,"abstract":"INTRODUCTION\u0000Diabetes mellitus (DM) is a metabolic disorder characterized by elevated level of blood glucose. It affects more than 422 million people globally. In resource limited settings, the progression of gestational diabetes (GDM) to DM was not well investigated and this research work was conducted to estimate the incidence of DM after GDM and their predictors in resource limited settings.\u0000\u0000\u0000METHODS\u0000A retrospective and prospective cohort studies were used from January 2010 until December 2019. The data were collected using patients chart review, interview and collecting blood sample. Initially, baseline data were collected from GDM and GDM free women and update data were collected every 3 month. Clinical nurses were used to extract the necessary data from medical charts and to collect the data using patient interview. Laboratory technologists were used to measure the blood glucose level of the study participants. The study was conducted in pregnant women presenting themselves in the referral hospitals of Amhara regional state. The sample size was calculated using Epi-info software. Descriptive statistics were used to describe the profile of study participants. Kaplan Meier survival curve and life-table were used to estimate the survivals of study participants. Incidence density was used to estimate the incidence of DM. Cox regression was used to identify the predictors DM.\u0000\u0000\u0000RESULTS\u0000A total of 4892 women were followed giving for the response rate of 88.62%. The mean age of study participants at the start of the study was 28.34 years with standard deviation [SD] ±7.48 years. DM was associated with gestational diabetes mellitus [AHR (adjusted hazard ratio); 2.53, 95% CI: 2.14-2.99], frequency of breastfeeding [AHR; 0.72, 95% CI: 0.69-0.74], age [AHR; 1.04, 95% CI: 1.03-1.05], parity [AHR; 1.14, 95% CI: 1.07-1.21], regular physical exercise [AHR; 0.45, 95% CI: 0.37-0.55], family history of DM [AHR; 2.04, 95% CI: 1.76-2.37], stillbirth [AHR; 1.67: 95% CI: 1.34-2.07], abortion [AHR; 2.64, 95% CI: 2.25-3.09].\u0000\u0000\u0000CONCLUSION\u0000The progression of GDM to DM was very high and special follow up should be implemented for women with a history of abortion, stillbirth, and family history of DM.","PeriodicalId":94177,"journal":{"name":"Primary care diabetes","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42002517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Primary care diabetes
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1